Ann Pharmacol Pharm | Volume 9, Issue 1 | Case Study | Open Access
Sattar SR* and Sattar SP
Department of Psychiatry and Addiction Medicine, Inroads to Recovery, USA
Fulltext PDFTirzepatide is Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor And Glucagon-like Peptide-1 (GLP-1) receptor agonist that mimics the GLP-1 hormone released in the gastrointestinal tract after eating. GLP-1 prompts the body to produce more insulin, which lowers blood glucose levels [1]. Tirzepatide has been evaluated as a treatment for type 2 diabetes, and reduce A1C levels and has been increasingly used to help with weight loss and obesity management [2,3]. While several side effects have been reported, abdominal pain and GI related side effects are more common [1]. But there are no published reports of Tirzepatide induced sexual dysfunction in a woman.
Sattar SR, Sattar SP. Tirzepatide Causes Sexual Dysfunction in Women. Ann Pharmacol Pharm. 2024; 9(1): 1212..